Trading IdeasFundamentals

IOL Chem and Pharma Ltd

NSE: IOLCP · Pharmaceuticals · sector

₹167.98NSE close 2026-10-26

Key numbers

Market cap₹4,931 cr
Price₹167.98
52w high / low₹224 / ₹67
P/E29.3xSector median 27.9x
P/B2.7xSector median 2.9x
Book value₹61.3
Dividend yield0.59%Sector median 0.48%
ROE9.6%Sector median 11.7%
ROCE12.4%Sector median 12.3%
OPM11.8%Sector median 14.0%
Debt / equity0.07xSector median 0.16x
EV/EBITDA16.2xSector median 18.6x
Interest cover17.2x
Current ratio1.78x
Sales growth 3y+1.5%Sector median +9.6%
Profit growth 3y-0.4%Sector median +13.3%
PEG–

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹209.39 · low ₹59.35
Mar 2025Aug 2025Jan 2026Jun 2026

Quarterly results

₹ crSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue526523528552568580619756
EBITDA42476362574692103
OPM %7.9%9.0%11.9%11.3%10.1%7.9%14.9%13.7%
Other income64577528
Net profit1921313430215364
EPS (₹)0.650.701.071.161.020.701.812.20
Revenue YoY+7.9%+10.9%+17.4%+37.1%
Profit YoY+56.5%+0.2%+69.2%+89.8%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ crFY22FY23FY24FY25FY26TTM
Revenue2,1842,2172,1332,0792,3192,524
EBITDA244226231202258299
Net profit168139134101138168
EPS (₹)5.714.744.583.444.695.73
Revenue growth+1.5%-3.8%-2.5%+11.5%+18.6%
Profit growth-17.0%-3.4%-24.8%+36.2%+60.1%
Dividend / share (₹)6.004.005.004.001.00
Compounded growth3 years5 yearsLast 12 months
Sales+1.5%+3.3%+18.6%
Net profit-0.4%-20.9%+60.1%
EPS-0.4%-21.0%–
Share price–+46.3% (2y)+83.1%

Balance sheet

₹ crFY22FY23FY24FY25FY26
Shareholders' equity–1,5081,6121,6881,799
Borrowings–8033117132
Cash & equivalents–24146211202
Total assets–2,0222,2442,3822,587
Fixed assets–7519221,1581,165
Capital work in progress–811002194
Investments–1701717
Receivables–505471514603
Inventory–326425361371
Payables–314469428483

Year-end figures from the March annual filing.

Cash flow

₹ crFY22FY23FY24FY25FY26
Cash from operations93122290179214
Cash from investing-120-120-191-154-198
Cash from financing-2-4-9246-29
Capex153212274214173
Free cash flow-60-9016-3541

Free cash flow = cash from operations − capex.

Ratios by year

₹ crFY22FY23FY24FY25FY26
ROE %–9.2%8.3%6.0%7.7%
ROCE %–12.9%12.0%8.5%10.3%
Debtor days–83819095
Inventory days–771119591
Payable days–74123112118
Cash conversion cycle (days)–86697368
Working capital days–76969585

Shareholding

Holder% (2026-09-30)
Promoters62.28%
FIIs7.25%
DIIs0.30%
of which Mutual funds0.29%
Government0.00%
Public (non-institutions)30.17%
QuarterDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters %52.62%52.62%52.62%52.62%52.62%57.48%62.28%62.28%
Promoter group%
NM Merchantiles Limited21.88%
Maya Devi Polycot Limited21.79%
Ncvi Enterprises Limited16.58%
Varinder Gupta2.04%
Dimple Gupta0.00%
Vikas Gupta0.00%
Abhiraj Gupta0.00%
Varinder Gupta (HUF)0.00%
Vikas Gupta (HUF)0.00%
Public holders above 1%%
Polunin Emerging Markets Small CAP Fund, LLC1.51%

1,32,241 shareholders. Pledged: 0.00% of promoter shares.

Peers in Pharmaceuticals

CompanyMarket capP/EP/BROEROCEOPMSales 3yDiv yield
SUNPHARMA₹4,17,478 cr34.5x5.0x15.5%18.7%28.6%+10.0%0.94%
DIVISLAB₹2,39,825 cr82.1x14.3x18.4%23.0%34.7%+10.8%0.34%
TORNTPHARM₹1,53,999 cr72.7x18.4x27.3%15.1%32.3%+13.3%0.84%
ZYDUSLIFE₹1,15,808 cr25.9x4.3x17.7%16.8%27.2%+16.4%0.95%
LAURUSLABS₹1,11,232 cr101.6x21.0x22.4%20.8%28.0%+4.1%0.08%
CIPLA₹1,09,464 cr32.5x3.2x10.3%13.2%17.7%+7.4%1.18%
DRREDDY₹1,09,460 cr33.9x2.9x9.0%10.1%15.5%+11.0%0.61%
MANKIND₹95,486 cr46.7x5.9x13.4%13.8%25.1%+17.7%0.04%
AUROPHARMA₹91,489 cr24.9x2.4x10.5%12.8%20.0%+10.6%0.26%
IOLCP₹4,931 cr29.3x2.7x9.6%12.4%11.8%+1.5%0.59%

All 185 companies in Pharmaceuticals →

Business segments (FY26)

SegmentRevenueShareEBITMargin
Pharmaceutical₹1,396 cr54.2%₹172 cr12.3%
Chemical₹1,160 cr45.0%₹30 cr2.6%
Unallocated₹21 cr0.8%₹0 cr0.0%

Dividends & corporate actions

Ex-dateActionDetail
2026-02-17DividendInterim Dividend - Re 1 Per Share
2025-03-11SplitFace Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
2025-02-18DividendInterim Dividend - Rs 4 Per Share
2024-08-16OtherAnnual General Meeting
2024-02-16DividendInterim Dividend - Rs 5 Per Share
2023-08-03OtherAnnual General Meeting
2023-02-17DividendInterim Dividend - Rs 4 Per Share
2022-08-18OtherAnnual General Meeting
2022-02-15DividendInterim Dividend - Rs 4 Per Share
2021-09-08DividendAnnual General Meeting/Dividend - Rs 2 Per Share
2020-11-17DividendInterim Dividend - Rs 4 Per Share
2020-09-17OtherAnnual General Meeting
2020-03-18DividendInterim Dividend - Rs 3 Per Share
2019-08-21OtherAnnual General Meeting
2018-09-19OtherAnnual General Meeting
2017-09-19OtherAnnual General Meeting
2016-09-19OtherAnnual General Meeting
2015-09-18OtherAnnual General Meeting
2014-09-19OtherAnnual General Meeting
2013-09-20OtherAnnual General Meeting

Documents

Links go to the original files on the exchange website.

About the company

SectorHealthcare
IndustryPharmaceuticals
Sub-industryPharmaceuticals
SymbolIOLCP
BSE code524164
ISININE485C01029
Face value₹2.0
Incorporated1986-09-29
Websitewww.iolcp.com
Plants (India / abroad)1 / 0

From the company's filings (BRSR FY26).

Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.